Evidence map›Paper›PMID 41885342›Full record

ArticleJournal of extracellular vesicles2026

Gut Commensal Klebsiella pneumoniae Extracellular Vesicles Shape a Liver Microenvironment Conducive to Gut-Liver Bacterial Translocation and Pro-Tumorigenic Processes.

Shogo Tsubaki, Sho Nashimoto, Rika Tanaka, Touya Toyomoto, Hiroyasu Tsutsuki, Ken Kato, Jun Nakayama, Kiminori Kimura, Kazuki Oshima, Yusuke Yamamoto and 11 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Shogo TsubakiTranskingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Sho NashimotoTranskingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Rika TanakaDepartment of Immunology, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Touya ToyomotoTranskingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Hiroyasu TsutsukiDepartment of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
Ken KatoDepartment of Head and Neck, Esophageal Medical Oncology / Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Jun NakayamaLaboratory of Integrative Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Kiminori KimuraDepartment of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kazuki OshimaDivision of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Yusuke YamamotoLaboratory of Integrative Oncology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Takuji OkusakaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Minoru EsakiDepartment of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Nobuhiro KawaiPreferred Medicine, Inc., Burlingame, California, USA.
Nobuyuki OtaPreferred Medicine, Inc., Burlingame, California, USA.
Yusuke YoshiokaDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Takahiro OchiyaDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0776-9918
Yoshimasa SaitoDivision of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Tomohiro SawaDepartment of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
Katsuto HozumiDepartment of Immunology, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Juntaro MatsuzakiDivision of Interdisciplinary Genetics and Nanomedicine, Research Center for Drug Discovery, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3204-5049
Hitoshi TsugawaTranskingdom Signaling Research Unit, Division of Host Defense Mechanism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-4344-4475

Funding

Foundation of Institute for Fermentation Osaka (IFO) G-2025-2-017Grant in Aid for Scientific Research (A), (B) 23H00554,25K02412Japan Agency for Medical Research and Development 21ck0106701h0001 22ck0106701h0002 23ck0106701h0003 25ck0106002h0001Reglia, IncShionogi Infectious Disease Research Promotion Foundation 2023S023Taiyo Kagaku Co. LtdTokai University School of Medicine Research Aid 22I331825TSUMURA & CO.
6 · The paper itself

Abstract

Bacterial extracellular vesicles (EVs) are emerging mediators of host-microbe communication; however, their role in human disease remains unclear. Here, we identify two bacterial small tRNAs (tsRNAs) enriched in gut commensal Klebsiella pneumoniae-derived EVs (KpEVs) that are markedly elevated in the serum of patients with hepatocellular carcinoma (HCC). These tsRNAs suppress the production of nitric oxide (NO) by macrophages, a critical antitumor molecule. Notably, KpEVs reach the liver more efficiently than bacterial cells, thus facilitating bacterial translocation from the gut by inducing distinctive immunosuppressive macrophages. Mechanistically, KpEVs drive an M2-like macrophage phenotype, enhance phagocytosis, and inhibit both NO production and caspase-1-dependent pyroptosis during infection. The results show that KpEVs shape a liver microenvironment promoting gut-liver bacterial translocation, which may also influence HCC progression. Our study uncovers a previously unrecognized strategy by which K. pneumoniae exploits EVs to modulate host immunity of distant organs, highlighting tsRNAs as potential biomarkers and therapeutic targets.

Indexed as

Bacterial TranslocationCarcinoma, HepatocellularExtracellular VesiclesGastrointestinal MicrobiomeKlebsiella pneumoniaeLiverLiver NeoplasmsAnimalsHumansKlebsiella InfectionsMacrophagesMiceNitric OxideTumor MicroenvironmentNitric Oxideextracellular vesiclesgut pathobiontmacrophagesnitric oxidesmall RNA

Identifiers

PMID41885342
PMCPMC13140988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.